<DOC>
	<DOC>NCT01902836</DOC>
	<brief_summary>Patients with atopic dermatitis treated with conventional treatment plus Dialyzed Leukocyte Extracts (DLE-oral Transferon) as adjuvant, have better clinical outcome than patients treated only with conventional treatment.</brief_summary>
	<brief_title>Efficacy Study of Dialyzed Leukocytes Extracts to Treat Paediatric Moderate Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Atopic dermatitis diagnosis by Hanifin and Rajka classification Dermatitis severity: Moderate, according with SCORAD index. Patients without treatment of topical steroids or immunosuppressants in the last 3 weeks. Patients with "informed consent form" signed by both parents, or advisor. Patients 7 years old or older whom have signed the assent form Patient who were treated with topical, or systemic steroids and/or immunosuppressants and they cannot discontinue their treatment. Patients who lived far from the hospital and they could not go to the visits.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Dialyzable Leukocyte Extracts</keyword>
	<keyword>Transferon</keyword>
	<keyword>atopic dermatitis</keyword>
</DOC>